Brief: Lipigon Says Prioritized Patent Application In US Confirmed

Lipigon Pharmaceuticals AB

02/03/2022 06:46

March 2 (Reuters) - Lipigon AB  LPGO.ST :
    * SAID ON TUESDAY PATENT FOR DRUG CANDIDATE LIPISENSE IS
SUBJECT
TO PRIORITIZED APPLICATION IN US 
    * APPLICATION WAS CONFIRMED BY U.S. PATENT AND TRADEMARK
OFFICE ON
FEBRUARY 18

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nBQN9ZLldg
 Further company coverage:  LPGO.ST  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))